SC S0749

Creates the Prescription Medicine Study Committee to examine methods for reducing costs of critical prescription medications, focusing on treatments for diabetes, heart disease, dementia, and other prevalent conditions in South Carolina

Committee must evaluate cost barriers including pricing structures, supply chains, and the role of pharmacy benefit managers, insurers, and pharmaceutical manufacturers

Committee will consider state-led initiatives such as bulk purchasing, state-supported pharmaceutical distribution, rebate reforms, and manufacturer transparency requirements

Membership includes 11 members: chairs or designees from relevant House and Senate committees, directors from state agencies (Insurance, Public Health, PEBA), representatives from the Medical Association and Hospital Association, plus one health plan representative and one pharmacy benefits manager representative appointed by the Governor

Committee must submit findings and recommendations, including proposed legislation, to the General Assembly by December 31, 2026, after which it dissolves unless reauthorized